Related Experiment Video
Updated: Aug 9, 2026

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
Published on: January 27, 2019
Immunological evidence for a bacterial toxin aetiology in sudden infant death syndrome
S Siarakas1, A J Brown, W G Murrell
1Department of Microbiology and Infectious Diseases, Concord Repatriation General Hospital, NSW, Australia. steven@micr.crg.cs.nsw.gov.au
Abstract:
Toxin-specific antibodies to clostridial, enterobacterial and staphylococcal toxins implicated in sudden infant death syndrome were studied in sera from sudden infant death syndrome infants and a comparison group of infants (babies with phenylketonuria). The results indicated a higher proportion of sera from sudden infant death syndrome infants contained IgA that bound to clostridial and enterobacterial toxins but a higher proportion of sera from the phenylketonuria comparison group contained IgA that bound staphylococcal toxins. The higher proportion of serum samples with IgG and IgM in the healthy comparison babies serum probably indicated immunity in this group of babies to these toxins. The effect of gender and age had a minimal effect on the incidence of these antibodies. The presence of toxin-specific antibodies in sudden infant death syndrome and the of comparison infants suggests that all infants are exposed to these toxins and most babies successfully overcome the toxic challenge. Some infants with predisposing risk factors (temperature change, smoking, infection, immune development, sleeping position, etc.) that could affect the baby's immune competency could succumb to these and possibly other toxins. This immunological evidence further strengthens the view that bacterial toxins are a significant cause of sudden infant death syndrome.
Related Concept Videos
Bacterial Toxins
Determinants of Bacterial Pathogenicity and Virulence
Botulism
Diphtheria
Bacterial Gastroenteritis
Bacterial Meningitis I: Introduction

